Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence

BACKGROUND: Excessive consumption of opioids is associated with impaired metabolic function including increased body mass index (BMI). Opioid antagonist naltrexone (NTX) is an effective treatment for opioid use disorder (OUD) that has the potential to mitigate such metabolic disturbances. Understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinyi, Langleben, Daniel D., Lynch, Kevin G., Wang, Gene-Jack, Elman, Igor, Wiers, Corinde E., Shi, Zhenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433165/
https://www.ncbi.nlm.nih.gov/pubmed/37599869
http://dx.doi.org/10.3389/fpsyt.2023.1247961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433165/
https://www.ncbi.nlm.nih.gov/pubmed/37599869
http://dx.doi.org/10.3389/fpsyt.2023.1247961

Ejemplares similares